Beijing Ql Biopharmaceutical Co.,ltd

This study tests a new drug called zovaglutide to help adults who are overweight or obese lose weight. About 744 participants will receive either the drug or a placebo for 52 weeks. The main goals are to see how much weight they lose and how many achieve at least a 5% weight loss…

This early-stage study looks at how an experimental long-acting drug called ZT002 affects the way the body processes four common medicines (metformin, warfarin, rosuvastatin, and digoxin) in overweight and obese adults aged 18 to 45. About 60 healthy volunteers will take these me…